Trials / Unknown
UnknownNCT01459601
Cabergoline Effect on Blood Sugar in Type 2 Diabetics
Cabergoline Effects on Blood Sugar Control in Type 2 Diabetics
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Mashhad University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cabergoline | 0,5mg per week |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2011-10-25
- Last updated
- 2011-10-25
Source: ClinicalTrials.gov record NCT01459601. Inclusion in this directory is not an endorsement.